![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Telkom Indonesia Persero Tbk PT | TG:PTI | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.10 | 16.70 | 17.40 | 0.00 | 07:20:03 |
RNS Number:9566N Protherics PLC 24 July 2003 Not for release, publication or distribution in or into the United States, Canada, Australia or Japan Recommended Offer by WestLB Panmure Limited ("Panmure") on behalf of Protherics PLC ("Protherics") to acquire the whole of the issued and to be issued share capital of Enact Pharma plc ("Enact") Compulsory acquisition of outstanding shares Protherics announces that it has received valid acceptances for more than nine-tenths in nominal value of the Enact Shares to which the Offer relates. Protherics is therefore entitled to use the procedures set out in sections 428 to 430F (inclusive) of the Companies Act 1985 to acquire compulsorily any Enact Shares for which it has not received valid acceptances of the Offer. Panmure, on behalf of Protherics, has today posted statutory notices to non-assenting shareholders pursuant to sections 428-430F (inclusive) of the Companies Act 1985 to acquire compulsorily all of the outstanding Enact Shares. The Offer remains open for acceptance until further notice. Enact Shareholders who have not yet accepted the Offer are urged to complete and return their Form of Acceptance as soon as possible. Terms defined in the Offer Document dated 7 May 2003 have the same meaning in this press release unless the context otherwise requires. Enquiries: Protherics PLC Andrew Heath, Chief Executive 020 7246 9950 Barry Riley, Finance Director 01928 518000 Panmure Dominic Morley 020 7020 5117 The Maitland Consultancy Brian Hudspith 020 7379 5151 Panmure, which is regulated in the United Kingdom by The Financial Services Authority, is acting exclusively for Protherics in connection with the Offer and no-one else and will not be responsible to anyone other than Protherics for providing the protections afforded to customers of Panmure, nor for giving advice in relation to the Offer. The Offer is not being made, directly or indirectly, in or into, or by the use of the mail of or by any means or instrumentality (including, without limitation, telephonically or electronically) of interstate or foreign commerce of, or any facility of a national securities exchange of, the United States, Canada, Australia or Japan. Accordingly, copies of this announcement are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in or into or from the United States, Canada, Australia or Japan and persons receiving this announcement (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send it in or into or from the United States, Canada, Australia or Japan. Doing so may render invalid any purported acceptance of the Offer. The availability of the Offer to persons who are not resident in the United Kingdom may be affected by the laws of the relevant jurisdictions. Any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves about and observe any applicable requirements. Neither the Protherics Convertible Loan Notes nor the NOIT Shares have been, or will be, registered under the US Securities Act or under the securities laws of any state of the United States; the relevant clearances have not been, nor will they be, obtained from the securities commission of any province or territory of Canada; no prospectus has been lodged with, or registered by, the Australian Securities and Investments Commission or the Japanese Ministry of Finance; and neither the Protherics Convertible Loan Notes nor the NOIT Shares have been, or will be, registered under or offered in compliance with applicable securities laws of any state, province, territory or jurisdiction of Canada, Australia or Japan. Accordingly, neither the Protherics Convertible Loan Notes nor the NOIT Shares may (unless an exemption under relevant securities laws is applicable) be offered, sold, resold or delivered, directly or indirectly, in or into the United States, Canada, Australia or Japan or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration thereof in, such jurisdiction or to, or for the account or benefit of, any United States, Canadian, Australian or Japanese person. This information is provided by RNS The company news service from the London Stock Exchange END OUPBIGDRDGDGGXS
1 Year Telkom Indonesia Persero... Chart |
1 Month Telkom Indonesia Persero... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions